Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bracci PM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 48
Tytuł:
Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS.
Autorzy:
McGrath MS; Department of Medicine, University of California San Francisco, San Francisco, CA 94110, USA.; Neuvivo, Inc., Palo Alto, CA 94301, USA.
Zhang R; Department of Medicine, University of California San Francisco, San Francisco, CA 94110, USA.
Bracci PM; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94158, USA.
Azhir A; Neuvivo, Inc., Palo Alto, CA 94301, USA.
Forrest BD; Neuvivo, Inc., Palo Alto, CA 94301, USA.; Hudson Innovations, LLC, Nyack, NY 10960, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Mar 28; Vol. 12 (7). Date of Electronic Publication: 2023 Mar 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Amyotrophic Lateral Sclerosis*
Humans ; Aged ; Disease Progression ; Respiration ; Immune System ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of cross-platform compatibility of a DNA methylation-based glucocorticoid response biomarker.
Autorzy:
Tang E; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Wiencke JK; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Warrier G; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Hansen H; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
McCoy L; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Rice T; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Bracci PM; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Wrensch M; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
Taylor JW; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
Clarke JL; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
Koestler DC; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, USA.
Salas LA; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
Christensen BC; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.; Departments of Molecular and Systems Biology, and Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.
Kelsey KT; Departments of Epidemiology and Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
Molinaro AM; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA. .; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2022 Oct 28; Vol. 14 (1), pp. 136. Date of Electronic Publication: 2022 Oct 28.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
DNA Methylation*
Glucocorticoids*/pharmacology
Adult ; Infant, Newborn ; Humans ; CpG Islands ; Oligonucleotide Array Sequence Analysis/methods ; Genetic Markers ; Dexamethasone/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Role of Bacteria in KSHV Infection and KSHV-Induced Cancers.
Autorzy:
Markazi A; Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Meng W; Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Bracci PM; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA 94158, USA.
McGrath MS; Department of Laboratory Medicine, Pathology and Medicine, University of California at San Francisco, San Francisco, CA 94143, USA.
Gao SJ; Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Aug 25; Vol. 13 (17). Date of Electronic Publication: 2021 Aug 25.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer.
Autorzy:
López de Maturana E; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Rodríguez JA; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Alonso L; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Lao O; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Molina-Montes E; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Martín-Antoniano IA; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Gómez-Rubio P; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Lawlor R; ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.
Carrato A; CIBERONC, Madrid, Spain.; Department of Oncology, Ramón y Cajal University Hospital, IRYCIS, Alcala University, Madrid, Spain.
Hidalgo M; Madrid-Norte-Sanchinarro Hospital, Madrid, Spain.; Weill Cornell Medicine, New York, USA.
Iglesias M; CIBERONC, Madrid, Spain.; Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Molero X; Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona and CIBEREHD, Barcelona, Spain.
Löhr M; Gastrocentrum, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Michalski C; Department of Surgery, Technical University of Munich, Munich, Germany.; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-WittenberHalle (Saale), Halle, Germany.
Perea J; Department of Surgery, Hospital 12 de Octubre, and Department of Surgery and Health Research Institute, Fundación Jiménez Díaz, Madrid, Spain.
O'Rorke M; Centre for Public Health, Queen's University Belfast, Belfast, UK.; College of Public Health, The University of Iowa, Iowa City, IA, USA.
Barberà VM; Molecular Genetics Laboratory, General University Hospital of Elche, Elche, Spain.
Tardón A; Department of Medicine, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; CIBERESP, Madrid, Spain.
Farré A; Department of Gastroenterology and Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Muñoz-Bellvís L; CIBERONC, Madrid, Spain.; Department of Surgery, Hospital Universitario de Salamanca - IBSAL, Universidad de Salamanca, Salamanca, Spain.
Crnogorac-Jurcevic T; Barts Cancer Institute, Centre for Molecular Oncology, Queen Mary University of London, London, UK.
Domínguez-Muñoz E; Department of Gastroenterology, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Gress T; Department of Gastroenterology, University Hospital of Giessen and Marburg, Marburg, Germany.
Greenhalf W; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
Sharp L; National Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland.; Newcastle University, Institute of Health & Society, Newcastle, UK.
Arnes L; Centre for Stem Cell Research and Developmental Biology, University of Copenhagen, Copenhagen, Denmark.; Department of Genetics and Development, Columbia University Medical Center, New York, NY, USA.; Department of Systems Biology, Columbia University Medical Center, New York, NY, USA.
Cecchini L; CIBERONC, Madrid, Spain.; Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Balsells J; Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona and CIBEREHD, Barcelona, Spain.
Costello E; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
Ilzarbe L; CIBERONC, Madrid, Spain.; Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Kleeff J; Department of Surgery, Technical University of Munich, Munich, Germany.; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-WittenberHalle (Saale), Halle, Germany.
Kong B; Department of Surgery, Technical University of Munich, Munich, Germany.
Márquez M; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Mora J; Department of Gastroenterology and Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
O'Driscoll D; National Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland.
Scarpa A; ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.
Ye W; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stokholm, Sweden.
Yu J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stokholm, Sweden.
García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Kogevinas M; CIBERESP, Madrid, Spain.; Institut Municipal d'Investigació Mèdica - Hospital del Mar, Centre de Recerca en Epidemiologia Ambiental (CREAL), Barcelona, Spain.
Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Silverman DT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Arslan AA; Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA.; Department of Environmental Medicine, New York University School of Medicine, New York, NY, USA.; Department of Population Health, New York University School of Medicine, New York, NY, USA.
Beane-Freeman L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Bracci PM; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Brennan P; International Agency for Research on Cancer (IARC), Lyon, France.
Bueno-de-Mesquita B; Deparment for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Buring J; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ, Heidelberg, Germany.
Du M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gallinger S; Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
Gaziano JM; Departments of Medicine, Brigham and Women's Hospital, VA Boston and Harvard Medical School, Boston, MA, USA.
Goodman PJ; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Gunter M; International Agency for Research on Cancer (IARC), Lyon, France.
LeMarchand L; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Li D; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Neale RE; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Peters U; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Petersen GM; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
Sánchez MJ; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.; Instituto de Investigación Biosanitaria Granada, Granada, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Universidad de Granada, Granada, Spain.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Thornquist MD; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Visvanathan K; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Easton D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wolpin BM; Department Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
Stolzenberg-Solomon RZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Klein AP; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Amundadottir LT; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Marti-Renom MA; National Centre for Genomic Analysis (CNAG), Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Universitat Pompeu Fabra (UPF), ICREA, Baldiri Reixac 4, 08028, Barcelona, Spain. .
Real FX; CIBERONC, Madrid, Spain.; Epithelial Carcinogenesis Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain. .; CIBERONC, Madrid, Spain. .
Pokaż więcej
Corporate Authors:
PanGenEU Investigators
SBC/EPICURO Investigators
Źródło:
Genome medicine [Genome Med] 2021 Feb 01; Vol. 13 (1), pp. 15. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Predisposition to Disease*
Genome-Wide Association Study*
Pancreatic Neoplasms/*genetics
Biomarkers, Tumor/genetics ; Cell Line, Tumor ; Computer Simulation ; Gene Regulatory Networks ; Genome, Human ; Humans ; Linkage Disequilibrium/genetics ; Reproducibility of Results ; Signal Transduction/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cognitive impact of lower-grade gliomas and strategies for rehabilitation.
Autorzy:
Weyer-Jamora C; Department of Neurological Surgery, University of California San Francisco.; Department of Psychiatry and Behavioral Sciences, Zuckerberg San Francisco General Hospital, California.
Brie MS; Department of Neurological Surgery, University of California San Francisco.; Department of Psychiatry and Behavioral Sciences, Zuckerberg San Francisco General Hospital, California.
Luks TL; Department of Radiology and Biomedical Imaging, University of California San Francisco.
Smith EM; Department of Neurological Surgery, University of California San Francisco.
Braunstein SE; Department of Radiation Oncology, University of California San Francisco.
Villanueva-Meyer JE; Department of Radiology and Biomedical Imaging, University of California San Francisco.
Bracci PM; Department of Epidemiology and Biostatistics, University of California San Francisco.
Chang S; Department of Neurological Surgery, University of California San Francisco.
Hervey-Jumper SL; Department of Neurological Surgery, University of California San Francisco.
Taylor JW; Department of Neurological Surgery, University of California San Francisco.; Department of Neurology, University of California San Francisco.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2020 Nov 04; Vol. 8 (2), pp. 117-128. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2021).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Genomic characterization of chronic lymphocytic leukemia (CLL) in radiation-exposed Chornobyl cleanup workers.
Autorzy:
Ojha J; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Dyagil I; National Research Center for Radiation Medicine, Kyiv, Ukraine.
Finch SC; Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Reiss RF; Department of Pathology and Cell Biology, and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
de Smith AJ; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Gonseth S; School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
Zhou M; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Hansen HM; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Sherborne AL; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Nakamura J; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Bracci PM; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Gudzenko N; National Research Center for Radiation Medicine, Kyiv, Ukraine.
Hatch M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Babkina N; National Research Center for Radiation Medicine, Kyiv, Ukraine.
Little MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Chumak VV; National Research Center for Radiation Medicine, Kyiv, Ukraine.
Walsh KM; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Bazyka D; National Research Center for Radiation Medicine, Kyiv, Ukraine.
Wiemels JL; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Zablotska LB; School of Medicine, University of California, San Francisco, San Francisco, CA, USA. .
Pokaż więcej
Źródło:
Environmental health : a global access science source [Environ Health] 2018 May 02; Vol. 17 (1), pp. 43. Date of Electronic Publication: 2018 May 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Chernobyl Nuclear Accident*
Occupational Exposure*
Radiation Exposure*
Genome, Human/*radiation effects
Leukemia, Lymphocytic, Chronic, B-Cell/*epidemiology
Neoplasms, Radiation-Induced/*epidemiology
Adult ; Case-Control Studies ; Female ; Follow-Up Studies ; Genomics ; Humans ; Incidence ; Leukemia, Lymphocytic, Chronic, B-Cell/etiology ; Male ; Middle Aged ; Neoplasms, Radiation-Induced/etiology ; Prevalence ; Radiation Dosage ; Ukraine/epidemiology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival.
Autorzy:
Wiencke JK; Department of Neurological Surgery, University of California San Francisco, 1450 3rd Street, San Francisco, CA 94158-0520 USA.
Koestler DC; Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS 66160 USA.
Salas LA; Computational Biology Core, University of California San Francisco, San Francisco, CA 94158 USA.
Wiemels JL; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94158 USA.
Roy RP; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158 USA.; Computational Biology Core, University of California San Francisco, San Francisco, CA 94158 USA.
Hansen HM; Department of Neurological Surgery, University of California San Francisco, 1450 3rd Street, San Francisco, CA 94158-0520 USA.
Rice T; Department of Neurological Surgery, University of California San Francisco, 1450 3rd Street, San Francisco, CA 94158-0520 USA.
McCoy LS; Department of Neurological Surgery, University of California San Francisco, 1450 3rd Street, San Francisco, CA 94158-0520 USA.
Bracci PM; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94158 USA.
Molinaro AM; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94158 USA.
Kelsey KT; Department of Epidemiology, Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912 USA.
Wrensch MR; Department of Neurological Surgery, University of California San Francisco, 1450 3rd Street, San Francisco, CA 94158-0520 USA.
Christensen BC; Departments of Epidemiology, Pharmacology & Toxicology, and Community and Family Medicine, Geisel School of Medicine at Dartmouth College, Lebanon, NH 03756 USA.
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2017 Feb 02; Vol. 9, pp. 10. Date of Electronic Publication: 2017 Feb 02 (Print Publication: 2017).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Brain Neoplasms/*genetics
Brain Neoplasms/*immunology
Glioma/*genetics
Glioma/*immunology
Adult ; Algorithms ; Brain Neoplasms/blood ; CpG Islands ; Epigenesis, Genetic ; Female ; Glioma/blood ; Humans ; Leukocyte Count ; Lymphocyte Count ; Male ; Middle Aged ; Proportional Hazards Models ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
Autorzy:
Childs EJ; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
Mocci E; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Campa D; 1] Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. [2] Department of Biology, University of Pisa, Pisa, Italy.
Bracci PM; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Gallinger S; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Goggins M; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Li D; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Neale RE; Department of Population Health, QIMR Berghofer Medical Research Institute, Kelvin Grove,Queensland, Australia.
Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Scelo G; International Agency for Research on Cancer (IARC), Lyon, France.
Amundadottir LT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
Bamlet WR; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Bijlsma MF; Laboratory for Experimental Oncology and Radiobiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Blackford A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Borges M; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Brennan P; International Agency for Research on Cancer (IARC), Lyon, France.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Bueno-de-Mesquita HB; 1] Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. [2] Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands. [3] Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. [4] Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Capurso G; Digestive and Liver Disease Unit, 'Sapienza' University of Rome, Rome, Italy.
Cavestro GM; Università Vita Salute San Raffaele and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Chaffee KG; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
Cleary SP; 1] Department of Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada. [2] Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Cotterchio M; 1] Cancer Care Ontario, University of Toronto, Toronto, Ontario, Canada. [2] Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and Medical Faculty Masaryk University, Brno, Czech Republic.
Fuchs C; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Funel N; Department of Surgery, Unit of Experimental Surgical Pathology, University Hospital of Pisa, Pisa, Italy.
Gazouli M; Department of Medical Sciences, Laboratory of Biology, School of Medicine, University of Athens, Athens, Greece.
Hassan M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Herman JM; Department of Radiation Oncology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Holcatova I; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Holly EA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
Hung RJ; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Janout V; Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.
Key TJ; Cancer Epidemiology Unit, University of Oxford, Oxford, UK.
Kupcinskas J; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Kurtz RC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Landi S; Department of Biology, Section of Genetics, University of Pisa, Pisa, Italy.
Lu L; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
Malecka-Panas E; Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland.
Mambrini A; Department of Oncology, Azienda USL 1 Massa Carrara, Massa Carrara, Italy.
Mohelnikova-Duchonova B; Laboratory of Toxicogenomics, Institute of Public Health, Prague, Czech Republic.
Neoptolemos JP; National Institute for Health Research (NIHR) Pancreas Biomedical Research Unit, Liverpool Clinical Trials Unit and Cancer Research UK Clinical Trials Unit, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Oberg AL; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pasquali C; Department of Surgery, Gastroenterology and Oncology, University of Padua, Padua, Italy.
Pezzilli R; Pancreas Unit, Department of Digestive Diseases, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
Rizzato C; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Saldia A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Scarpa A; ARC-NET-Centre for Applied Research on Cancer, University and Hospital Trust of Verona, Verona, Italy.
Stolzenberg-Solomon RZ; Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA.
Strobel O; Department of General Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Tavano F; Division of Gastroenterology and Research Laboratory, IRCCS Scientific Institute and Regional General Hospital 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, Italy.
Vashist YK; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Vodicka P; Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences, Prague, Czech Republic.
Wolpin BM; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Yu H; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Petersen GM; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
Klein AP; 1] Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. [2] Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Nature genetics [Nat Genet] 2015 Aug; Vol. 47 (8), pp. 911-6. Date of Electronic Publication: 2015 Jun 22.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Polymorphism, Single Nucleotide*
Chromosomes, Human, Pair 17/*genetics
Chromosomes, Human, Pair 2/*genetics
Chromosomes, Human, Pair 3/*genetics
Chromosomes, Human, Pair 7/*genetics
Genetic Predisposition to Disease/*genetics
Pancreatic Neoplasms/*genetics
Aged ; Australia ; Europe ; Female ; Gene Frequency ; Genetic Loci/genetics ; Genome-Wide Association Study/methods ; Genotype ; Humans ; Male ; Middle Aged ; North America ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 48

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies